Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Groupon Inc (GRPN)’s New Head Honcho, Top-Line Thoughts, Fiksu & More

Editor’s Note: Groupon Inc (NASDAQ:GRPN)

Groupon Pins Turnaround on Billionaire Investor Lefkofsky (Bloomberg)
Groupon Inc (NASDAQ:GRPN)’s choice of Eric Lefkofsky as permanent chief executive officer entrusts the daily deals site’s Groupon Inc (NASDAQ:GRPN)turnaround plans to a controversial Chicago billionaire with a history of failed endeavors. Lefkofsky — one constant at a company that has cycled through executives and dabbled in new business models to make up for waning demand in its main coupon business — has shored up control after jostling with his co-founder Andrew Mason, whom he helped oust from the CEO role in February. While the move puts Groupon Inc (NASDAQ:GRPN) in the hands of a known quantity, who as interim co-CEO helped oversee a 79 percent stock rally this year, it also dashed optimism that the board would tap an outsider with experience leading corporate overhauls. In May, the company said the search for a new chief was under way and it was talking with recruiting firms.

Groupon’s top-line fundamentals still lacking – RBC (Financial post)
The market seemed to like Groupon Inc (NASDAQ:GRPN) ’s second-quarter results, driving the stock up some 25% after the online daily deal provider reported on Wednesday afternoon. But some on the Street don’t think the stock warrants a much higher valuation just yet

Groupon, Fiksu Extend Partnership – Analyst Blog (Nasdaq)
Daily deals provider Groupon Inc (NASDAQ:GRPN) and Boston-based marketing services provider Fiksu recently expanded their 3-year old relationship. The companies signed an extended partnership deal, which will allow Fiksu to exclusively market Groupon’s mobile applications worldwide. Per the latest agreement, Fiksu will use its Mobile App Marketing platform to market Groupon mobile app in the under penetrated regions of Europe, Middle East and Africa (“EMEA”) and Asia-Pacific (“APAC). Currently, Fiksu provides services to Groupon in North America only. Fiksu’s marketing platform uses technology that analyzes user data collected from different sources, including mobile ad networks, real-time bidding exchanges and social networks such as Facebook ( FB ) . This thorough analysis helps advertisers to target the right audience at significantly lower costs (one-third of traditional providers), which improves their return on investment (“ROI”).

Is Groupon Goods a Daily-Deal Savior or a Low-Margin Distraction? (All Things D)
When Groupon recognized in 2011 that daily deals alone wouldn’t lead it to long-term success, the company started selling discounted products under the Groupon Goods banner.That business has continued to grow strongly since then, accounting for $151 million in revenue in North America in the first quarter, and $229 million globally. As the Chicago-based daily-deal company prepares to report second-quarter earnings on Wednesday, it’s clear that analysts will be paying close attention to this business segment.

Discussing Groupon’s Future With Piper Jaffray’s Gene Munster (Benzinga)
Piper Jaffray’s managing director and senior research analyst Gene Munster talked to the folks at CNBC’s Squawk Box about Groupon’s recent success, evolving business and future competitors. Munster noted that the company can keep up with its current trajectory path, saying that the company is very different from a year ago. Over the past year, Groupon has shifted from pushing their product via email to pulling in people by keeping up better deals for longer periods of time, which ultimately makes it easier for those searching the site to find good deals, he said.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!